Biobank Partnerships NeuroLex has built a large biobank of voice samples, supported by pharmaceutical and academic partners, and its SurveyLex platform enables rapid creation of voice surveys. This positions the company to co-create biomarker studies, sponsor data collection, and license access to its labeled data and analytics for drug development and precision health.

SurveyLex Platform SurveyLex provides a fast, web-based way to deploy voice surveys and collect labeled data. There is an opportunity to upsell to pharmaceutical companies, CROs, and research labs as an end-to-end data collection and analytics solution, including enterprise features, API access, and secure data workflows.

Academic Network NeuroLex collaborates with a broad academic network, spanning multiple universities and researchers, with peer‑reviewed publications behind its work. This network can be leveraged to broker sponsored research, data-sharing agreements, and co-branded studies that validate and extend the product’s capabilities.

Regional Cloud Pilot Based in Boston and built on cloud platforms including Microsoft Azure, NeuroLex has strong potential for regional pilots with local hospitals and research centers, integrating SurveyLex into existing clinical workflows while emphasizing data security and compliance.

Digital Biomarker Edge The market is increasingly focused on digital biomarkers and early health detection, making NeuroLex’s speech-based approach timely. Its combination of a large labeled data repository and cross-institution collaborations can be monetized through data access licenses, analytics services, or white-labeled survey platforms for pharma, medical device developers, and payers.